Lucrative Prospects for India-UK Pharma Trade (India)
This article was originally published in PharmAsia News
Executive Summary
A new study predicts India-U.K. trade will increase by 60 percent over the next three years, and that U.K. pharmaceutical companies in particular will see great outsourcing opportunities as well as investment opportunities in India. The report by the Federation of Indian Chambers of Commerce and Industry (FICCI) and Yes Bank will be released soon, and says that U.K.-India pharmaceutical cooperation should be strong especially in the fields of clinical trials, generic drug production, business and data process outsourcing, and some targeted marketing opportunities. Today India's pharmaceutical industry is ranked fourth worldwide in volume and thirteenth worldwide in value. India's pharmaceutical industry generates around $10 billion annually, China around $11 billion annually, Japan around $60 billion annually, and the United States around $263 billion annually. Indian officials hope to surpass China in the near future. (Click here for more